Goldman Sachs
MYOK

Goldman Sachs’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Goldman Sachs’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,400
Closed -$1.2M – 5642
2020
Q2 		$1.2M Sell
12,400
-3,300
-21% -$275K ﹤0.01% 3831
2020
Q1 		$736K Sell
15,700
-32,400
-67% -$2.08M ﹤0.01% 3958
2019
Q4 		$3.51M Buy
+48,100
New +$2.92M ﹤0.01% 3231

Goldman Sachs's MYOK Position: Q4 2020 in Review

Goldman Sachs sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 314,091 shares — an estimated $42.8M sold.

Goldman Sachs first reported a position in MYOK in Q4 2016 and held it in 16 quarters. The position peaked at $42.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Goldman Sachs reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 314,091 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $42.8M.
  • Goldman Sachs first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 16 quarters.
  • Goldman Sachs's MyoKardia, Inc. Common Stock position peaked at $42.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.